- Bone Health
- Immunology
- Hematology
- Respiratory
- Dermatology
- Diabetes
- Gastroenterology
- Neurology
- Oncology
- Ophthalmology
- Rare Disease
- Rheumatology
Sonia T. Oskouei, PharmD: Biosimilar Education
Sonia T. Oskouei, PharmD, vice president of innovation and solution development at Premier Inc, discusses biosimilar education.
Transcript
I think it needs to be multifacted for multistakeholder education, and it needs to come from different areas. I think the FDA did a great job of releasing the whole biosimilar educational campaign, but if it’s not being utilized, it’s just sitting there, then we’re not leveraging those resources. So it’s being proactive again with the education, utilizing what’s out there, working with different societies and foundations to have that information embedded in the education as well is very important.
Newsletter
Where clinical, regulatory, and economic perspectives converge—sign up for Center for Biosimilars® emails to get expert insights on emerging treatment paradigms, biosimilar policy, and real-world outcomes that shape patient care.
